Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hosts

Autor: Nadège Bercovici, Karine Goude, Christophe Combadière, Karine Bailly, Roland S. Liblau, Nathalie Pardigon, Csaba Vizler, Agnès Heurtier
Přispěvatelé: CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Biologie Moléculaire du Gène, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), This work was supported by Agence Nationale de la Recherches sur le SIDA, Fondation de France, and Institut National de la Santé et de la Recherche Médicale., Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)
Jazyk: angličtina
Rok vydání: 2000
Předmět:
MESH: T-Lymphocyte Subsets/transplantation
Adoptive cell transfer
MESH: Diabetes Mellitus
Type 1/pathology

Epitopes
T-Lymphocyte

Hemagglutinin Glycoproteins
Influenza Virus

CD8-Positive T-Lymphocytes
MESH: Promoter Regions
Genetic/immunology

medicine.disease_cause
Lymphocyte Activation
[SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity
Autoimmunity
Mice
MESH: Pancreas/pathology
0302 clinical medicine
Cell Movement
T-Lymphocyte Subsets
MESH: Islets of Langerhans/immunology
Tumor Cells
Cultured

Immunology and Allergy
Cytotoxic T cell
Insulin
MESH: Animals
Promoter Regions
Genetic

Cells
Cultured

0303 health sciences
Mice
Inbred BALB C

geography.geographical_feature_category
MESH: Cell Movement/genetics
MESH: Diabetes Mellitus
Type 1/immunology

MESH: Epitopes
T-Lymphocyte/immunology

MESH: CD8-Positive T-Lymphocytes/transplantation
Cell Differentiation
Islet
Adoptive Transfer
3. Good health
MESH: CD8-Positive T-Lymphocytes/immunology
Interleukin 12
MESH: Diabetes Mellitus
Type 1/genetics

MESH: Cells
Cultured

endocrine system
MESH: Rats
MESH: Mice
Transgenic

Immunology
MESH: Mice
Inbred BALB C

MESH: Cell Movement/immunology
Mice
Transgenic

Biology
MESH: CD8-Positive T-Lymphocytes/pathology
03 medical and health sciences
Islets of Langerhans
MESH: Lymphocyte Activation/genetics
MESH: T-Lymphocyte Subsets/immunology
medicine
Animals
MESH: Tumor Cells
Cultured

MESH: Insulin/genetics
Pancreas
MESH: Mice
MESH: T-Lymphocyte Subsets/pathology
030304 developmental biology
geography
CD40
MESH: Diabetes Mellitus
Type 1/etiology

MESH: Islets of Langerhans/pathology
MESH: Cell Differentiation/genetics
In vitro
Rats
MESH: Adoptive Transfer
Diabetes Mellitus
Type 1

MESH: Pancreas/immunology
MESH: Hemagglutinin Glycoproteins
Influenza Virus/genetics

MESH: Cell Differentiation/immunology
biology.protein
CD8
030215 immunology
Zdroj: Journal of Immunology
Journal of Immunology, 2000, 165 (11), pp.6314-21. ⟨10.4049/jimmunol.165.11.6314⟩
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2000, 165 (11), pp.6314-21. ⟨10.4049/jimmunol.165.11.6314⟩
ResearcherID
ISSN: 0022-1767
1550-6606
DOI: 10.4049/jimmunol.165.11.6314⟩
Popis: CD8+ T cells are important effectors, as well as regulators, of organ-specific autoimmunity. Compared with Tc1-type CD8+ cells, Tc2 cells have impaired anti-viral and anti-tumor effector functions, although no data are yet available on their pathogenic role in autoimmunity. Our aim was to explore the role of autoreactive Tc1 and Tc2 cells in autoimmune diabetes. We set up an adoptive transfer model in which the recipients were transgenic mice expressing influenza virus hemagglutinin (HA) specifically in their pancreatic β islet cells (rat insulin promoter-HA mice) and islet-specific Tc1 and Tc2 cells were generated in vitro from HA-specific CD8+ cells of TCR transgenic mice (CL4-TCR mice). One million Tc1 cells, differentiated in vitro in the presence of IL-12, transferred diabetes in 100% of nonirradiated adult rat insulin promoter-HA recipients; the 50% diabetogenic dose was 5 × 105. Highly polarized Tc2 cells generated in the presence of IL-4, IL-10, and anti-IFN-γ mAb had a relatively low, but definite, diabetogenic potential. Thus, 5 × 106 Tc2 cells caused diabetes in 6 of 18 recipients, while the same dose of naive CD8+ cells did not cause diabetes. Looking for the cause of the different diabetogenic potential of Tc1 and Tc2 cells, we found that Tc2 cells are at least as cytotoxic as Tc1 cells but their accumulation in the pancreas is slower, a possible consequence of differential chemokine receptor expression. The diabetogenicity of autoreactive Tc2 cells, most likely caused by their cytotoxic activity, precludes their therapeutic use as regulators of autoimmunity.
Databáze: OpenAIRE